tiprankstipranks
Heron Therapeutics narrows 2024 revenue view to $140M-$146M from $138M-$158M
PremiumThe FlyHeron Therapeutics narrows 2024 revenue view to $140M-$146M from $138M-$158M
8d ago
Heron Therapeutics Inc (HRTX) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Heron Therapeutics Inc (HRTX) Q3 Earnings Cheat Sheet
11d ago
Heron Therapeutics Strengthens Leadership with New Board Appointment
Premium
Company Announcements
Heron Therapeutics Strengthens Leadership with New Board Appointment
16d ago
Heron Therapeutics reports Q2 EPS (6c), consensus (4c)
PremiumThe FlyHeron Therapeutics reports Q2 EPS (6c), consensus (4c)
4M ago
Is HRTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is HRTX a Buy, Before Earnings?
4M ago
Heron Therapeutics management to meet virtually with Needham
Premium
The Fly
Heron Therapeutics management to meet virtually with Needham
4M ago
Heron Therapeutics announces acceptance of PAS application for ZYNRELE
PremiumThe FlyHeron Therapeutics announces acceptance of PAS application for ZYNRELE
5M ago
Heron Therapeutics initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Heron Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
Heron Therapeutics Submits ZYNRELEF® Supplement to FDA
Premium
Company Announcements
Heron Therapeutics Submits ZYNRELEF® Supplement to FDA
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100